DK3083562T3 - Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorer - Google Patents
Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorerInfo
- Publication number
- DK3083562T3 DK3083562T3 DK14827907.8T DK14827907T DK3083562T3 DK 3083562 T3 DK3083562 T3 DK 3083562T3 DK 14827907 T DK14827907 T DK 14827907T DK 3083562 T3 DK3083562 T3 DK 3083562T3
- Authority
- DK
- Denmark
- Prior art keywords
- cyclic
- activity
- receptor modulators
- phenoxyethylamine derivatives
- phenoxyethylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361916827P | 2013-12-17 | 2013-12-17 | |
| PCT/US2014/069743 WO2015094902A1 (en) | 2013-12-17 | 2014-12-11 | Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3083562T3 true DK3083562T3 (da) | 2017-11-13 |
Family
ID=52355185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14827907.8T DK3083562T3 (da) | 2013-12-17 | 2014-12-11 | Cykliske phenoxyethylaminderivater og deres aktivitet som EP4-receptormodulatorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9776964B2 (da) |
| EP (1) | EP3083562B1 (da) |
| JP (1) | JP6212644B2 (da) |
| KR (1) | KR101807981B1 (da) |
| CN (1) | CN105793242B (da) |
| AU (1) | AU2014366361B2 (da) |
| BR (1) | BR112016011016A8 (da) |
| CA (1) | CA2928593A1 (da) |
| CY (1) | CY1119583T1 (da) |
| DK (1) | DK3083562T3 (da) |
| EA (1) | EA028921B1 (da) |
| ES (1) | ES2651858T3 (da) |
| HR (1) | HRP20171850T1 (da) |
| HU (1) | HUE035698T2 (da) |
| LT (1) | LT3083562T (da) |
| ME (1) | ME02896B (da) |
| MX (1) | MX2016007566A (da) |
| NO (1) | NO3221486T3 (da) |
| PL (1) | PL3083562T3 (da) |
| PT (1) | PT3083562T (da) |
| RS (1) | RS56615B1 (da) |
| SI (1) | SI3083562T1 (da) |
| WO (1) | WO2015094902A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20180323A (es) | 2015-11-20 | 2018-08-06 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituídos como moduladores de los receptores de pge2 |
| MX394108B (es) | 2017-05-18 | 2025-03-21 | Idorsia Pharmaceuticals Ltd | Derivados de indol n-sustituidos. |
| TW201900180A (zh) | 2017-05-18 | 2019-01-01 | 瑞士商愛杜西亞製藥有限公司 | 嘧啶衍生物 |
| CN110612296A (zh) | 2017-05-18 | 2019-12-24 | 爱杜西亚药品有限公司 | 作为pge2受体调节剂的苯基衍生物 |
| AU2018268311B2 (en) | 2017-05-18 | 2022-02-10 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives as PGE2 receptor modulators |
| JP7093791B2 (ja) | 2017-05-18 | 2022-06-30 | イドーシア ファーマシューティカルズ リミテッド | Ｐｇｅ２レセプター調節剤としてのベンゾフラン及びベンゾチオフェン誘導体 |
| CN109970625B (zh) * | 2017-12-28 | 2021-02-26 | 新发药业有限公司 | 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法 |
| JP2022536607A (ja) * | 2019-06-11 | 2022-08-18 | テオン セラピューティクス，インク． | プロスタグランジンｅ２受容体４アンタゴニスト及びその使用 |
| EP3885339A1 (en) * | 2020-03-27 | 2021-09-29 | Rottapharm Biotech S.r.l. | Process for the preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof |
| KR20230107228A (ko) | 2020-11-13 | 2023-07-14 | 오노 야꾸힝 고교 가부시키가이샤 | Ep4 길항약과 면역 체크포인트 저해 물질의 병용에 의한 암 치료 |
| CN112608271A (zh) * | 2020-11-26 | 2021-04-06 | 安润医药科技（苏州）有限公司 | 酰胺衍生物及其在制备ep4受体拮抗剂中的应用 |
| GB202211232D0 (en) | 2022-08-02 | 2022-09-14 | Heptares Therapeutics Ltd | Prostaglandin EP4 receptor agonist compounds |
| CN117164507A (zh) * | 2023-05-26 | 2023-12-05 | 康化（上海）新药研发有限公司 | 一种阿加曲班杂质(2r,4r)-4-甲基-2-哌啶甲酸的合成方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2500157C2 (de) | 1975-01-03 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung |
| WO2003077910A1 (en) | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Methods of treatment with selective ep4 receptor agonists |
| PT1660491E (pt) * | 2003-07-28 | 2008-10-10 | Janssen Pharmaceutica Nv | Derivados de benzimidazole, benzotiazole e benzoxazole e a sua utilização como moduladores de lta4h |
| RS20060143A (sr) | 2003-09-03 | 2008-06-05 | Pfizer Inc., | Jedinjenja fenil ili piridil amida kao antagonisti prostaglandina e2 |
| CN1950334A (zh) | 2004-05-04 | 2007-04-18 | 辉瑞有限公司 | 邻位取代的芳基或杂芳基酰胺化合物 |
| MXPA06011555A (es) * | 2004-05-04 | 2006-12-15 | Pfizer | Compuestos de metil-aril o heteroaril-amida sustituida. |
| CA2648729A1 (en) * | 2006-04-24 | 2007-11-01 | Merck Frosst Canada Ltd. | Indole amide derivatives as ep4 receptor antagonists |
| US7705035B2 (en) | 2006-06-12 | 2010-04-27 | Merck Frosst Canada Ltd. | Indoline amide derivatives as EP4 receptor ligands |
| EP2460787A1 (en) * | 2007-07-03 | 2012-06-06 | Astellas Pharma Inc. | Amide compounds and their use as PGE2 antagonists. |
| US8598355B2 (en) * | 2008-05-14 | 2013-12-03 | Astellas Pharma Inc. | Amide compound |
| US8404736B2 (en) | 2008-08-14 | 2013-03-26 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as EP4 receptor antagonists |
| BR112012020236A2 (pt) | 2010-02-22 | 2016-05-17 | Raqualia Pharma Inc | uso de um composto com atividade antagonística de ep4 ou um sal farmaceuticamente aceitável do mesmo, uso de um composto da fórmula (i), (ii), (iii), (iv), (va) ou (vb), ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e método para o tratamento de doenças mediadas por il-23 em um sujeito animal, incluindo um sujeito mamífero |
| RU2565596C2 (ru) | 2011-07-04 | 2015-10-20 | Роттафарм Биотек С.Р.Л. | Производные циклических аминов в качестве антагонистов рецептора ер4 |
| ES2564353T3 (es) * | 2011-07-04 | 2016-03-22 | Rottapharm Biotech S.R.L. | Derivados de aminas cíclicas como agonistas de los receptores EP4 |
| AR091429A1 (es) * | 2012-06-29 | 2015-02-04 | Lilly Co Eli | Compuestos de fenoxietil piperidina |
| TW201443004A (zh) | 2013-02-15 | 2014-11-16 | Lilly Co Eli | 苯氧基乙氧基化合物 |
| TWI636046B (zh) * | 2013-05-17 | 2018-09-21 | 美國禮來大藥廠 | 苯氧基乙基二氫－１ｈ－異喹啉化合物 |
-
2014
- 2014-12-11 CN CN201480068170.1A patent/CN105793242B/zh not_active Expired - Fee Related
- 2014-12-11 MX MX2016007566A patent/MX2016007566A/es unknown
- 2014-12-11 JP JP2016538744A patent/JP6212644B2/ja not_active Expired - Fee Related
- 2014-12-11 AU AU2014366361A patent/AU2014366361B2/en not_active Ceased
- 2014-12-11 LT LTEP14827907.8T patent/LT3083562T/lt unknown
- 2014-12-11 KR KR1020167015741A patent/KR101807981B1/ko not_active Expired - Fee Related
- 2014-12-11 EA EA201690894A patent/EA028921B1/ru not_active IP Right Cessation
- 2014-12-11 CA CA2928593A patent/CA2928593A1/en not_active Abandoned
- 2014-12-11 PT PT148279078T patent/PT3083562T/pt unknown
- 2014-12-11 RS RS20171227A patent/RS56615B1/sr unknown
- 2014-12-11 HR HRP20171850TT patent/HRP20171850T1/hr unknown
- 2014-12-11 ES ES14827907.8T patent/ES2651858T3/es active Active
- 2014-12-11 HU HUE14827907A patent/HUE035698T2/en unknown
- 2014-12-11 SI SI201430434T patent/SI3083562T1/sl unknown
- 2014-12-11 ME MEP-2017-238A patent/ME02896B/me unknown
- 2014-12-11 US US15/030,888 patent/US9776964B2/en not_active Expired - Fee Related
- 2014-12-11 PL PL14827907T patent/PL3083562T3/pl unknown
- 2014-12-11 BR BR112016011016A patent/BR112016011016A8/pt not_active IP Right Cessation
- 2014-12-11 WO PCT/US2014/069743 patent/WO2015094902A1/en not_active Ceased
- 2014-12-11 DK DK14827907.8T patent/DK3083562T3/da active
- 2014-12-11 EP EP14827907.8A patent/EP3083562B1/en active Active
-
2015
- 2015-10-02 NO NO15775410A patent/NO3221486T3/no unknown
-
2017
- 2017-11-09 CY CY20171101176T patent/CY1119583T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3083562T3 (pl) | 2018-02-28 |
| AU2014366361A1 (en) | 2016-05-19 |
| US9776964B2 (en) | 2017-10-03 |
| RS56615B1 (sr) | 2018-02-28 |
| SI3083562T1 (sl) | 2017-11-30 |
| EP3083562B1 (en) | 2017-09-27 |
| CY1119583T1 (el) | 2018-03-07 |
| KR20160084467A (ko) | 2016-07-13 |
| US20160272585A1 (en) | 2016-09-22 |
| BR112016011016A8 (pt) | 2018-01-30 |
| HRP20171850T1 (hr) | 2018-01-12 |
| EA201690894A1 (ru) | 2016-10-31 |
| HUE035698T2 (en) | 2018-05-28 |
| CA2928593A1 (en) | 2015-06-25 |
| AU2014366361B2 (en) | 2017-04-20 |
| NO3221486T3 (da) | 2018-09-08 |
| KR101807981B1 (ko) | 2017-12-11 |
| EP3083562A1 (en) | 2016-10-26 |
| EA028921B1 (ru) | 2018-01-31 |
| WO2015094902A1 (en) | 2015-06-25 |
| CN105793242B (zh) | 2018-02-16 |
| ME02896B (me) | 2018-04-20 |
| ES2651858T3 (es) | 2018-01-30 |
| LT3083562T (lt) | 2018-01-10 |
| JP2016540007A (ja) | 2016-12-22 |
| MX2016007566A (es) | 2016-10-03 |
| JP6212644B2 (ja) | 2017-10-11 |
| CN105793242A (zh) | 2016-07-20 |
| PT3083562T (pt) | 2017-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3363438T3 (da) | Substituerede 2-azabicykler og deres anvendelse som orexinreceptormodulatorer | |
| IL245848B (en) | Octahydro fused azadecalin glucocorticoid receptor modulators | |
| DK2875005T3 (da) | N-(3-heteroarylaryl)-4-arylarylcarboxamider og analoger som hedgehog pathway inhibitorer, og anvendelse deraf | |
| DK2989092T3 (da) | Quinazolinonderivater, der er anvendelige som fgfr-kinasemodulatorer | |
| DK2831079T3 (da) | BICYKLISKE HETEROCYKLISKE DERIVATER SOM MNK1- og MNK2-MODULATORER OG ANVENDELSER DERAF | |
| DK3377483T3 (da) | N-substituerede indolderivater som pge2-receptormodulatorer | |
| IL235590A0 (en) | Phototherapy devices and methods | |
| ES2635318T7 (es) | Moduladores P2X7 | |
| DK2841429T3 (da) | Tetrazolinonforbindelser og anvendelse deraf som pesticider | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| DK3288940T3 (da) | Azabenzimidazoler og deres anvendelse som ampa-receptormodulatorer | |
| DK2999699T3 (da) | Purindioner som wnt-vej-modulatorer | |
| DK2970442T3 (da) | Gla-domæner som terapeutiske midler | |
| PT3083562T (pt) | Derivados de aminas cíclicas de fenoxietilo e a sua atividade como moduladores de recetores ep4 | |
| DK2861573T3 (da) | Oxathiazin-derivater som antibakterielle og anticancer-stoffer | |
| DK3319963T3 (da) | Substituerede 4-azaindoler og deres anvendelse som glun2b receptormodulatorer | |
| BR302012004223S1 (pt) | Configuracao aplicada em relogio | |
| DK2917181T3 (da) | Heteroarylderivater og anvendelser deraf | |
| IL231440A0 (en) | Selective androgen receptor modulators | |
| DK2809669T3 (da) | Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika | |
| KR101335984B9 (ko) | 스프링클러헤드 고정장치 | |
| EP2961397A4 (en) | TRANSDERMAL FORMULATIONS | |
| DK2875016T3 (da) | Carbamat-/urinstofderivater | |
| DK2903652T3 (da) | Hydroxylerede polyaminderivater som transfektionsreagenser | |
| DK2903651T3 (da) | Carboxylerede polyaminderivater som transfektionsreagenser |